Cosmo Pharmaceuticals N.V. (OTCPK:CMOPF) Monday said that Glenmark had received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi in the United Kingdom.

Winlevi is the first topical acne treatment in nearly 40 years with a